Mid-America Transplant Services
1
8M
1
0.02
1
- Areas of investment
Summary
Mid-America Transplant Services appeared to be the Corporate Investor, which was created in 1974. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the St Louis.
The top activity for fund was in 2007. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2016.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Mid-America Transplant Services, startups are often financed by National Institutes of Health, NIST. The meaningful sponsors for the fund in investment in the same round are Life Sciences Partners, Ascension Ventures, Alafi Capital.
We can highlight the next thriving fund investment areas, such as Information Technology, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Isto Technologies.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.02
- Investments by industry
- Information Technology (1)
- Biotechnology (1)
- Medical Device (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 24
- Group Appearance index
- 1.00
- Avg. company exit year
- 19
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.